Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. total revenue, net income and dynamics of changes in Hong Kong dollar today
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. revenue for the past few reporting periods. The dynamics of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. net revenue decreased by -211 386 088 $ from the last reporting period. The dynamics of net income of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. has changed by -74 697 554 $ in recent years. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. online financial report chart. The value of the "total revenue of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd." on the chart is marked in yellow. The value of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
The dates of the latest financial statements of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.: 31/03/2019, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is available online for such a date - 31/03/2021. Gross profit Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is 118 553 642 $
Cost of revenue Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is 7 649 814 $ Total revenue Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is 126 203 456 $ Operating income Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is -4 352 635 $
Net income Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is 5 117 336 $ Current assets Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is 1 932 887 591 $ Total assets Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. refers to the total amount of assets owned by a person or entity. Total assets Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is 2 412 291 449 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
128 088 688.77 $
336 435 617.07 $
260 009 780.34 $
197 640 267.01 $
326 661 103.78 $
326 661 103.78 $
189 758 832.33 $
189 758 832.33 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
8 265 074.17 $
28 305 619.92 $
21 547 900.72 $
19 415 793.59 $
18 320 551.72 $
18 320 551.72 $
21 299 019.78 $
21 299 019.78 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
136 353 762.94 $
364 741 237 $
281 557 681.06 $
217 056 060.60 $
344 981 655.50 $
344 981 655.50 $
211 057 852.11 $
211 057 852.11 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
344 981 655.50 $
344 981 655.50 $
211 057 852.11 $
211 057 852.11 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-4 702 709.26 $
87 792 424.61 $
56 466 020.58 $
34 419 706.48 $
91 451 255.55 $
91 451 255.55 $
42 978 890.47 $
42 978 890.47 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
5 528 913.72 $
86 234 251.70 $
60 254 415.38 $
51 174 449.90 $
74 402 593.54 $
74 402 593.54 $
48 419 386.28 $
48 419 386.28 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
49 402 133.98 $
39 870 959.03 $
51 852 443.40 $
58 746 124.75 $
41 394 414.54 $
41 394 414.54 $
27 656 799.06 $
27 656 799.06 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
141 056 472.20 $
276 948 812.38 $
225 091 660.48 $
182 636 354.12 $
253 530 399.95 $
253 530 399.95 $
168 078 961.64 $
168 078 961.64 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
2 088 346 109.78 $
2 189 567 728.70 $
2 126 626 990.86 $
2 118 996 932.91 $
1 229 785 796.70 $
1 229 785 796.70 $
999 406 817.03 $
999 406 817.03 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
2 606 307 519.71 $
2 701 827 724.83 $
2 610 496 375.19 $
2 595 693 379.79 $
1 690 680 452.89 $
1 690 680 452.89 $
1 644 002 119.27 $
1 644 002 119.27 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
1 470 660 315.53 $
1 509 239 446.64 $
1 530 688 517.35 $
1 652 301 164.26 $
623 190 303.26 $
623 190 303.26 $
528 747 477.29 $
528 747 477.29 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
617 302 109.37 $
617 302 109.37 $
535 118 761.92 $
535 118 761.92 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
682 480 988.63 $
682 480 988.63 $
550 308 500.89 $
550 308 500.89 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
40.37 %
40.37 %
33.47 %
33.47 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
2 180 322 226.51 $
2 172 666 135.64 $
2 080 909 493.84 $
2 020 799 826.66 $
1 006 446 215.73 $
1 006 446 215.73 $
1 088 094 839.85 $
1 088 094 839.85 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
92 649 743.13 $
92 649 743.13 $
52 793 499.53 $
52 793 499.53 $
Last revenue report of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. was 31/03/2021. According to last financial report total revenue in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. was 136 353 762.94 Hong Kong dollar and changed by -35.395% since last year. Net income in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. was 5 528 913.72 $ in last quartal, net income changes to -88.581%.
Current cash Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. - the sum of all of the cash a company has on the date of report. Current cash Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is 1 361 182 929 $
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. stocks data
